Merck says research shows its COVID-19 pill works against variants
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does not target the spike...
www.yahoo.com
Perhaps we need a cure and not a vaccine or both? But this is very encouraging.